{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T06:26:58Z","timestamp":1784356018853,"version":"3.55.0"},"reference-count":17,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T00:00:00Z","timestamp":1753747200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","pathologyjournal.rcpa.edu.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.pathol.2025.05.013","type":"journal-article","created":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T06:34:24Z","timestamp":1753770864000},"page":"30-33","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["T-cell immunoreceptor with Ig and ITIM domains (TIGIT) is extensively expressed in the microenvironment of nodular lymphocyte-predominant Hodgkin lymphoma and T-cell-\/histiocyte-rich large B-cell lymphoma"],"prefix":"10.1016","volume":"58","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0864-935X","authenticated-orcid":false,"given":"Georgia","family":"Karpathiou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Somaia","family":"Chokoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mousa","family":"Mobarki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"P\u00e9oc'h","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.pathol.2025.05.013_bib1","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/ni.1674","article-title":"The surface protein TIGIT suppresses T cell activation by promoting the generation of mature immunoregulatory dendritic cells","volume":"10","author":"Yu","year":"2009","journal-title":"Nat Immunol"},{"issue":"2","key":"10.1016\/j.pathol.2025.05.013_bib2","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1136\/gut.49.2.236","article-title":"Overexpression of the CD155 gene in human colorectal carcinoma","volume":"49","author":"Masson","year":"2001","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.pathol.2025.05.013_bib3","doi-asserted-by":"crossref","first-page":"6211","DOI":"10.1038\/s41467-024-50474-y","article-title":"Orchestrating NK and T cells via tri-specific nano-antibodies for synergistic antitumor immunity","volume":"15","author":"Ye","year":"2024","journal-title":"Nat Commun"},{"issue":"3","key":"10.1016\/j.pathol.2025.05.013_bib4","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1097\/PAS.0000000000002168","article-title":"TIGIT is frequently expressed in the tumor microenvironment of select lymphomas: implications for targeted therapy","volume":"48","author":"Libert","year":"2024","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1016\/j.pathol.2025.05.013_bib5","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.pathol.2019.10.003","article-title":"Nodular lymphocyte predominant Hodgkin lymphoma: pathology, clinical course and relation to T-cell\/histiocyte rich large B-cell lymphoma","volume":"52","author":"Hartmann","year":"2020","journal-title":"Pathology"},{"issue":"4","key":"10.1016\/j.pathol.2025.05.013_bib6","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s00428-023-03554-1","article-title":"The spectrum of nodular lymphocyte predominant Hodgkin lymphoma: a report of the lymphoma workshop of the 20th meeting of the European Association for Haematopathology","volume":"483","author":"Hartmann","year":"2023","journal-title":"Virchows Arch"},{"issue":"1","key":"10.1016\/j.pathol.2025.05.013_bib7","doi-asserted-by":"crossref","first-page":"7059","DOI":"10.1038\/s41598-021-86655-8","article-title":"A novel scoring system for TIGIT expression in classic Hodgkin lymphoma","volume":"11","author":"Annibali","year":"2021","journal-title":"Sci Rep"},{"issue":"8","key":"10.1016\/j.pathol.2025.05.013_bib8","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1097\/PAS.0b013e318165b0d6","article-title":"PD-1, a follicular T-cell marker useful for recognizing nodular lymphocyte-predominant Hodgkin lymphoma","volume":"32","author":"Nam-Cha","year":"2008","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1016\/j.pathol.2025.05.013_bib9","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1186\/s12885-018-5111-1","article-title":"Expression of the immune checkpoint receptor TIGIT in Hodgkin's lymphoma","volume":"18","author":"Li","year":"2018","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.pathol.2025.05.013_bib10","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/s41408-024-01073-z","article-title":"Spatial phenotyping of nodular lymphocyte predominant Hodgkin lymphoma and T-cell\/histiocyte-rich large B-cell lymphoma","volume":"14","author":"Younes","year":"2024","journal-title":"Blood Cancer J"},{"issue":"6","key":"10.1016\/j.pathol.2025.05.013_bib11","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-006582","article-title":"TIGIT is a key inhibitory checkpoint receptor in lymphoma","volume":"11","author":"Godfrey","year":"2023","journal-title":"J Immunother Cancer"},{"issue":"19","key":"10.1016\/j.pathol.2025.05.013_bib12","doi-asserted-by":"crossref","first-page":"5217","DOI":"10.1158\/1078-0432.CCR-20-0558","article-title":"TIGIT expression is associated with T-cell suppression and exhaustion and predicts clinical outcome and anti-PD-1 response in follicular lymphoma","volume":"26","author":"Yang","year":"2020","journal-title":"Clin Cancer Res"},{"issue":"3","key":"10.1016\/j.pathol.2025.05.013_bib13","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1158\/2326-6066.CIR-18-0351","article-title":"TIGIT and PD-1 mark intratumoral T cells with reduced effector function in B-cell non-Hodgkin lymphoma","volume":"7","author":"Josefsson","year":"2019","journal-title":"Cancer Immunol Res"},{"issue":"4","key":"10.1016\/j.pathol.2025.05.013_bib14","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1158\/1078-0432.CCR-17-2337","article-title":"T cells expressing checkpoint receptor TIGIT are enriched in follicular lymphoma tumors and characterized by reversible suppression of T-cell receptor signaling","volume":"24","author":"Josefsson","year":"2018","journal-title":"Clin Cancer Res"},{"issue":"Supplement 1","key":"10.1016\/j.pathol.2025.05.013_bib15","doi-asserted-by":"crossref","first-page":"3513","DOI":"10.1182\/blood-2021-145840","article-title":"The NLPHL tumor microenvironment is markedly enriched in the tigit and PD-1 signalling axes compared to classical Hodgkin lymphoma","volume":"138","author":"Gunawardana","year":"2021","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.pathol.2025.05.013_bib16","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1002\/ajh.27459","article-title":"Intra-tumoral and peripheral blood TIGIT and PD-1 as immune biomarkers in nodular lymphocyte predominant Hodgkin lymphoma","volume":"99","author":"Gunawardana","year":"2024","journal-title":"Am J Hematol"},{"issue":"8","key":"10.1016\/j.pathol.2025.05.013_bib17","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1158\/2159-8290.CD-21-1586","article-title":"Sequential single-cell transcriptional and protein marker profiling reveals TIGIT as a marker of CD19 CAR-T cell dysfunction in patients with non-Hodgkin lymphoma","volume":"12","author":"Jackson","year":"2022","journal-title":"Cancer Discov"}],"container-title":["Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031302525002296?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031302525002296?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T17:39:51Z","timestamp":1768585191000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0031302525002296"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":17,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S0031302525002296"],"URL":"https:\/\/doi.org\/10.1016\/j.pathol.2025.05.013","relation":{},"ISSN":["0031-3025"],"issn-type":[{"value":"0031-3025","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"T-cell immunoreceptor with Ig and ITIM domains (TIGIT) is extensively expressed in the microenvironment of nodular lymphocyte-predominant Hodgkin lymphoma and T-cell-\/histiocyte-rich large B-cell lymphoma","name":"articletitle","label":"Article Title"},{"value":"Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pathol.2025.05.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V. on behalf of Royal College of Pathologists of Australasia.","name":"copyright","label":"Copyright"}]}}